ATE517178T1 - Multipotente neurale stammzellen - Google Patents
Multipotente neurale stammzellenInfo
- Publication number
- ATE517178T1 ATE517178T1 AT06837847T AT06837847T ATE517178T1 AT E517178 T1 ATE517178 T1 AT E517178T1 AT 06837847 T AT06837847 T AT 06837847T AT 06837847 T AT06837847 T AT 06837847T AT E517178 T1 ATE517178 T1 AT E517178T1
- Authority
- AT
- Austria
- Prior art keywords
- stem cells
- neural stem
- multipotent neural
- multipotent
- olig2
- Prior art date
Links
- 210000001178 neural stem cell Anatomy 0.000 title abstract 2
- 102100039289 Glial fibrillary acidic protein Human genes 0.000 abstract 1
- 101710193519 Glial fibrillary acidic protein Proteins 0.000 abstract 1
- 101710150593 Protein beta Proteins 0.000 abstract 1
- 102000004243 Tubulin Human genes 0.000 abstract 1
- 208000036815 beta tubulin Diseases 0.000 abstract 1
- 210000005046 glial fibrillary acidic protein Anatomy 0.000 abstract 1
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Neurosurgery (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US73811905P | 2005-11-17 | 2005-11-17 | |
| PCT/US2006/044593 WO2007061805A2 (en) | 2005-11-17 | 2006-11-17 | Multipotent neural stem cells |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE517178T1 true ATE517178T1 (de) | 2011-08-15 |
Family
ID=37998366
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06837847T ATE517178T1 (de) | 2005-11-17 | 2006-11-17 | Multipotente neurale stammzellen |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1969119B1 (de) |
| AT (1) | ATE517178T1 (de) |
| AU (1) | AU2006318791B2 (de) |
| CA (1) | CA2629551A1 (de) |
| WO (1) | WO2007061805A2 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010018996A2 (ko) * | 2008-08-12 | 2010-02-18 | 연세대학교 산학협력단 | 인간 신경줄기세포 및 이를 이용한 중추 또는 말초 신경계 질환 및 손상 치료용 약학적 조성물 |
| WO2010046876A1 (en) * | 2008-10-22 | 2010-04-29 | Universidade De Coimbra | Method for the Functional identification of SVZ-derived oligodendrocytes based on selective resuponse to thrombin and utilization thereof |
| GB201300684D0 (en) | 2013-01-15 | 2013-02-27 | Apitope Int Nv | Peptide |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968829A (en) * | 1997-09-05 | 1999-10-19 | Cytotherapeutics, Inc. | Human CNS neural stem cells |
| AU2003278741B2 (en) * | 2002-08-27 | 2008-02-14 | Stemcells California Inc. | Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
-
2006
- 2006-11-17 AT AT06837847T patent/ATE517178T1/de not_active IP Right Cessation
- 2006-11-17 CA CA002629551A patent/CA2629551A1/en not_active Abandoned
- 2006-11-17 EP EP06837847A patent/EP1969119B1/de not_active Not-in-force
- 2006-11-17 WO PCT/US2006/044593 patent/WO2007061805A2/en not_active Ceased
- 2006-11-17 AU AU2006318791A patent/AU2006318791B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007061805A3 (en) | 2007-11-01 |
| EP1969119B1 (de) | 2011-07-20 |
| CA2629551A1 (en) | 2007-05-31 |
| AU2006318791A1 (en) | 2007-05-31 |
| WO2007061805A2 (en) | 2007-05-31 |
| EP1969119A2 (de) | 2008-09-17 |
| AU2006318791B2 (en) | 2012-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY159971A (en) | Multipotent/pluripotent cells and methods | |
| DE602008003684D1 (de) | Gezielte integration in die ppp1r12c-position | |
| CL2019003586A1 (es) | Composiciones y métodos para enzimas de internalización. | |
| CU20120095A7 (es) | Antagonistas de pcsk9 | |
| MX2021012461A (es) | Procesos para preparar y usar un secretoma derivado de células madre mesenquimales. | |
| BRPI0510674A (pt) | variantes fc otimizadas | |
| MX2022010490A (es) | Composiciones utiles para enzimas de internalizacion. | |
| WO2009058957A3 (en) | Intranasal administration of active agents to the central nervous system | |
| EP4287191A3 (de) | Verfahren und zusammensetzungen auf hla-basis und verwendungen davon | |
| NO20083324L (no) | Multisykliske aminosyrederivater og anvendelse derav | |
| WO2007002385A3 (en) | Mesoderm and definitive endoderm cell populations | |
| NO20080462L (no) | Krystallformer av astaxantin | |
| WO2006083782A3 (en) | Directed differentiation of embryonic stem cells and uses thereof | |
| WO2010093954A3 (en) | Control of plant stress tolerance, water use efficiency and gene expression using novel aba receptor proteins and synthetic agonists | |
| EA200971077A1 (ru) | Гетероциклические модуляторы киназы | |
| EP4223769A3 (de) | Nuklearer neuprogrammierungsfaktor | |
| ES2571355T3 (es) | Sistema de cultivo sin células alimentadoras ni xenocontaminantes para células madre embrionarias humanas | |
| HN2005029978A (es) | Formulaciones | |
| NZ598176A (en) | Disintegrin variants and pharmaceutical uses thereof | |
| PH12015502849B1 (en) | Biomarkers for cognitive dysfunction diseases and method for detecting cognitive dysfunction disease using biomarkers | |
| NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
| ATE553778T1 (de) | Für humanes hepcidin spezifische antikörper | |
| MX2019001946A (es) | Marcador para celulas madre neurales. | |
| NZ730124A (en) | A method of predicting risk of recurrence of cancer | |
| ATE523587T1 (de) | Eigenschaften neuronaler vorläuferzellen zeigende zellen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |